26/01/2021 11:47:12 AM | Source: Reuters
Novartis fourth-quarter sales, core net income trail analyst expectations
ZURICH - Novartis's fourth-quarter sales and profit rose less than analysts expected, as the Swiss drugmaker said on Tuesday that the COVID-19 pandemic affected divisions including opthalmology, dermatology and its generics unit.
Core net income in the final three months of 2020 rose 3% in constant currencies to $3.03 billion, compared to the average forecast of $3.15 billion in a Refinitiv poll of analysts. Sales rose 1% to $12.77 billion, compared to $12.88 billion forecast in the poll.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
India`s cement demand to rise 6-7 pc in FY26 led by ...
1st phase of India`s Deep Ocean Mission on track for...
India poised to emerge as centre of gravity in new w...
India`s industrial production registers 1.2 per cent...
Adani Group, ISKCON serve devotion with nutrition du...
Adani Electricity observes National Electrical Safet...
IPO Note : HDB Financial Services Ltd by Choice Broking
Black Box eyes scalable growth with data centre and ...
IPO Note : Sambhv Steel Tubes Ltd by Choice Broking Ltd
`Backbone of rising India`: PM Narendra Modi highli...
